UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 360

Sortiert nach

Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling

The Journal of biological chemistry, 2019-05, Vol.294 (19), p.7692-7710

2019

Volltextzugriff (PDF)

Targeting PI3‐kinase (PI3K), AKT and mTOR axis in lymphoma

British journal of haematology, 2014-10, Vol.167 (1), p.19-32

2014

Volltextzugriff (PDF)

Versatility of PRMT5-induced methylation in growth control and development

Trends in biochemical sciences (Amsterdam. Regular ed.), 2011-12, Vol.36 (12), p.633-641

2011

Volltextzugriff (PDF)

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

Blood, 2010-09, Vol.116 (13), p.2286-2294

2010

Volltextzugriff (PDF)

Profiling of immune related genes silenced in EBV-positive gastric carcinoma identified novel restriction factors of human gammaherpesviruses

PLoS pathogens, 2020-08, Vol.16 (8), p.e1008778-e1008778

2020

Volltextzugriff (PDF)

Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy

Expert opinion on therapeutic targets, 2018-06, Vol.22 (6), p.527-545

2018

Volltextzugriff (PDF)

Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma

The Journal of biological chemistry, 2020-01, Vol.295 (5), p.1165-1180

2020

Volltextzugriff (PDF)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals

Frontiers in oncology, 2020-09, Vol.10, p.1723-1723

2020

Volltextzugriff (PDF)

Genotypes Distribution of Epstein–Barr Virus among Lymphoma Patients in Ethiopia

International journal of molecular sciences, 2023-09, Vol.24 (18), p.13891

2023

Volltextzugriff (PDF)

BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor

Cancer discovery, 2018-04, Vol.8 (4), p.458-477

2018

Volltextzugriff (PDF)

Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma

PloS one, 2021-05, Vol.16 (5), p.e0250839-e0250839

2021

Volltextzugriff (PDF)

Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing

The Journal of biological chemistry, 2013-12, Vol.288 (49), p.35534-35547

2013

Volltextzugriff (PDF)

Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro

Journal for immunotherapy of cancer, 2019-05, Vol.7 (1), p.140-140, Article 140

2019

Volltextzugriff (PDF)

Effect of Malaria Infection on Epstein-Barr Virus Persistence in Kenyan Children

The Journal of infectious diseases, 2024-01, Vol.229 (1), p.73-82

2024

Volltextzugriff (PDF)

Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases

Current hematologic malignancy reports, 2016-12, Vol.11 (6), p.514-527

2016

Volltextzugriff (PDF)

Driving toward targeted therapy for LCH

Blood, 2014-09, Vol.124 (10), p.1546-1548

Baiocchi, Robert A.

2014

Volltextzugriff (PDF)

NKp80 Defines a Critical Step during Human Natural Killer Cell Development

Cell reports (Cambridge), 2016-07, Vol.16 (2), p.379-391

2016

Volltextzugriff (PDF)

Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function

JCI insight, 2021-03, Vol.6 (6)

2021

Volltextzugriff (PDF)

Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma

The EMBO journal, 2007-08, Vol.26 (15), p.3558-3569

2007

Volltextzugriff (PDF)

Cutaneous involvement of Erdheim‐Chester disease in a patient with Burkitt lymphoma

Journal of cutaneous pathology, 2021-07, Vol.48 (7), p.928-931

2021

Volltextzugriff (PDF)

A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas

The Journal of clinical investigation, 2022-12, Vol.132 (24), p.1-16

2022

Volltextzugriff (PDF)

Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma

The Journal of biological chemistry, 2020-01, Vol.295 (5), p.1165-1180

2020

Volltextzugriff (PDF)

PRMT5 as a druggable target for glioblastoma therapy

Neuro-oncology (Charlottesville, Va.), 2018-05, Vol.20 (6), p.753-763

2018

Volltextzugriff (PDF)

A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter?

Leukemia & lymphoma, 2024-07, Vol.65 (8), p.1-1116

2024

Volltextzugriff (PDF)

1 – 25 von 360

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(342)
Mit Volltextzugriff
(343)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling

Targeting PI3‐kinase (PI3K), AKT and mTOR axis in lymphoma

Versatility of PRMT5-induced methylation in growth control and development

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody

Profiling of immune related genes silenced in EBV-positive gastric carcinoma identified novel restriction factors of human gammaherpesviruses

Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy

Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals

Genotypes Distribution of Epstein–Barr Virus among Lymphoma Patients in Ethiopia

BRD4 Profiling Identifies Critical Chronic Lymphocytic Leukemia Oncogenic Circuits and Reveals Sensitivity to PLX51107, a Novel Structurally Distinct BET Inhibitor

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation

Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma

Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing

Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro

Effect of Malaria Infection on Epstein-Barr Virus Persistence in Kenyan Children

Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases

Driving toward targeted therapy for LCH

NKp80 Defines a Critical Step during Human Natural Killer Cell Development

Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function

Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma

Cutaneous involvement of Erdheim‐Chester disease in a patient with Burkitt lymphoma

A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas

Protein arginine methyltransferase 5 represses tumor suppressor miRNAs that down-regulate CYCLIN D1 and c-MYC expression in aggressive B-cell lymphoma

PRMT5 as a druggable target for glioblastoma therapy

A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter?

Suchergebnisse filtern